Noevir Holdings Co Ltd
TSE:4928

Watchlist Manager
Noevir Holdings Co Ltd Logo
Noevir Holdings Co Ltd
TSE:4928
Watchlist
Price: 4 415 JPY 0.46%
Market Cap: ¥150.8B

Noevir Holdings Co Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Noevir Holdings Co Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Noevir Holdings Co Ltd
TSE:4928
Free Cash Flow
¥5.4B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
6%
Shiseido Co Ltd
TSE:4911
Free Cash Flow
¥65.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
7%
Rohto Pharmaceutical Co Ltd
TSE:4527
Free Cash Flow
¥30.6B
CAGR 3-Years
26%
CAGR 5-Years
23%
CAGR 10-Years
11%
Kao Corp
TSE:4452
Free Cash Flow
¥128.8B
CAGR 3-Years
34%
CAGR 5-Years
-2%
CAGR 10-Years
2%
F
Fancl Corp
TSE:4921
Free Cash Flow
¥10.1B
CAGR 3-Years
29%
CAGR 5-Years
13%
CAGR 10-Years
15%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Free Cash Flow
¥11.6B
CAGR 3-Years
-10%
CAGR 5-Years
-10%
CAGR 10-Years
0%
No Stocks Found

Noevir Holdings Co Ltd
Glance View

Market Cap
150.8B JPY
Industry
Consumer products

In the versatile world of beauty and wellness, Noevir Holdings Co Ltd. stands as a testament to astute innovation combined with a well-honed business acumen. Founded in Japan, this company has expertly navigated the delicate balance of tradition and modernity to emerge as a prominent figure in the skincare and cosmetic industries. Noevir's strategy is rooted in the meticulous formulation of its products, drawing inspiration from natural ingredients, which reflects the company’s keen attention to quality and detail. By leveraging advanced research and development techniques, Noevir crafts a diverse range of skincare and personal care products designed to cater to the discerning needs of its clientele. They operate primarily through direct sales channels, allowing them to maintain a personal relationship with their customers, understanding their preferences deeply and ensuring a consistent brand experience. Financially, Noevir Holdings generates revenue by employing a multi-faceted business model, anchoring itself in both domestic and international markets. Besides its leading role in the cosmetics sector, the company diversifies through its involvement in pharmaceuticals and health foods, broadening its portfolio to mitigate market risks. This diversity not only stabilizes the company’s revenue streams but also aligns with the increasing consumer emphasis on holistic health and wellness solutions. Noevir's ability to anticipate and respond to market trends ensures its growth trajectory, having firmly established its brand in the Asian market while progressively expanding its footprint across regions. As a result, the company's strategy encompasses not just product innovation but also a robust marketing and distribution network that reinforces its position as a leader in the beauty and wellness industry.

Intrinsic Value
4 176.78 JPY
Overvaluation 5%
Intrinsic Value
Price ¥4 415

See Also

What is Noevir Holdings Co Ltd's Free Cash Flow?
Free Cash Flow
5.4B JPY

Based on the financial report for Dec 31, 2025, Noevir Holdings Co Ltd's Free Cash Flow amounts to 5.4B JPY.

What is Noevir Holdings Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
6%

Over the last year, the Free Cash Flow growth was -12%. The average annual Free Cash Flow growth rates for Noevir Holdings Co Ltd have been 2% over the past three years , -1% over the past five years , and 6% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett